Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oklahoma Cardiovascular and Hypertension Center (OCHC) is a specialized clinical research facility and medical practice based in Oklahoma City, Oklahoma. The center focuses on the diagnosis, treatment, and clinical study of cardiovascular diseases, hypertension, and related metabolic conditions such as diabetes and lipid disorders. OCHC serves as a key site for Phase II through IV clinical trials, collaborating with global pharmaceutical companies to evaluate the safety and efficacy of new therapeutic agents. Led by recognized experts in the field, the center combines advanced diagnostic capabilities with a commitment to improving patient outcomes through innovative research and comprehensive care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oklahoma Cardiovascular and Hypertension Center.